The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
Two of the most influential minds in immuno-oncology walk into a biotech… and build something that could change everything.
Dr. Rachel Humphrey (CEO) and Dr. Melinda Merchant (CMO) of Normunity are two of the most seasoned and respected leaders in oncology drug development, with a combined 45+ years of experience across big pharma, biotech, and translational science. Rachel led the development of Yervoy® (ipilimumab) at BMS, Imfinzi® (durvalumab) at AstraZeneca, and Nexavar® (sorafenib) at Bayer, before holding CMO roles at Black Diamond, Mirati, and CytomX. Melinda, an immunologist and dual board-certified pediatric oncologist, spent a decade leading clinical studies at NIH and Memorial Sloan Kettering, running early trials of ipilimumab, nivolumab, and novel cell therapies before moving to industry and leading clinical development efforts of multiple investigational new drugs. Together, they now lead Normunity, where they’re pioneering a bold new therapeutic category: immune normalizers - designed to unlock immune resistance and open up new frontiers in cancer treatment.In this episode, we cover:
- How Normunity is redefining immuno-oncology with its first-in-class T-cell engager
- What it takes to build scientific teams that challenge each other - and still move fast
- Lessons from launching Yervoy, Imfinzi, Tazverik, and other breakthrough therapies
- Why biotech culture needs both humility and ego to succeed
- What’s next as Normunity prepares to enter the clinic with NRM-823
If you're a life sciences leader, founder, or investor - this conversation is essential listening. Tap in to hear what it really takes to build, lead, and scale science that matters.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com
Youtube: https://www.youtube.com/@life_sciences
Rachel Humphrey
CEO at Normunity
LinkedIn: https://www.linkedin.com/in/rachel-w-humphrey-md-116b211b/
Melinda Merchant
CMO at Normunity
LinkedIn: https://www.linkedin.com/in/melinda-merchant-7b496a/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
16:58 Traits of a Drug Developer
19:53 Leadership in Biotech
27:28 Story Behind Normunity
30:23 Normunity Culture
32:28 Mindsets in Translational Science
36:33 Personal Life
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.